Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Alex Waldman BS

Alex David Waldman BS

MD/PhD Student, National Institutes of Health Oxford-Cambridge Scholars Program, Neurodegeneration and Inflammation Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom; Molecular Development of the Immune System Section, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland; Emory Medical Scientist Training Program, Atlanta, Georgia

Alex David Waldman is an MD/PhD student at Emory University School of Medicine and a National Institutes of Health Oxford-Cambridge Scholar. He graduated from the University of Wisconsin-Madison in May 2016 where he earned comprehensive honors degrees in both Neurobiology and Spanish, while simultaneously earning certificates in Global Health, European Studies, and Stem Cell Sciences.

His graduate work is co-mentored by Dr. Michael Lenardo (NIH/NIAID) and Dr. Gabriele De Luca (Oxford/NDCN). Over the course of his graduate research career, Alex has used a neuropathological lens to uncover novel determinants of spinal cord pathology in multiple sclerosis.

Outside the research laboratory and clinic, he has served as a national leader for the American Physician Scientists Association and will soon begin his term as president. In various roles, he has focused on cultivating and expanding strategic partnerships to ultimately better serve current and future physician-scientist trainees.

As a future physician-scientist, Alex hopes to continue conducting interdisciplinary collaborative research that can ultimately lead to breakthroughs that effect change clinically.


Alex Waldman has no relevant disclosures.